NXP800 in subjects with Ovarian Cancer

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-509150-64-00

Acronym

NXP800-101

Enrollment

Registered

2024-03-25

Start date

Unknown

Completion date

2025-08-05

Last updated

2024-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARID1a-mutated ovarian, fallopian tube and primary peritoneal carcinoma, Platinum-resistant

None listed

Sex/Gender

All

Age

18 Years to No maximum

Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026